Richard, the problem is, most of the medical devices cos. are fairly large and often diversified. Heck, even with their new aliases, Perkin Elmer (now PE Bio) and Beckman Instruments (now Beckman-coultier) are the class acts, and they are not likely to be fast growers. Another choice is Hewlett Packard, but I hear they do other things, too. <g> I would probably go with BEC if I was forced to, but I'd like to see it a bit cheaper. Another one I've had great luck with over the decades is something of a peripheral play, Bausch and Lomb. But they are at the top of their trading range and I am not likely to buy here.
There are many cos. in this space, but not very many good cos. or very many with superior tech advantages over the competition. The reagents cos. were a great play back during Billary, but they have gotten way past my price range.
So, I agree with you on fundamentals, but I am still leery of the valuations. |
